Synonyms Metastatic Pancreatic Islet Cell Tumor, Metastatic Pancreatic Neuroendocrine Neoplasm, Metastatic Pancreatic Neuroendocrine Tumor + [6] |
Introduction A neuroendocrine tumor that arises from the islet cells of the pancreas and has spread to another anatomic site. |
Target |
Mechanism PDL1 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date23 Mar 2017 |
Target |
Mechanism TYMP inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date24 Mar 2014 |
Mechanism AXL inhibitors [+10] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date29 Nov 2012 |
Start Date15 Nov 2024 |
Sponsor / Collaborator |
Start Date14 Aug 2024 |
Sponsor / Collaborator |
Start Date07 Mar 2023 |
Sponsor / Collaborator |